



Sudden cardiac death in epilepsy disappoints, 
but epileptologists keep faith
Apesar do desapontamento com a morte súbita cardíaca nas epilepsias, os epileptologistas 
mantêm a fé
Fulvio A. Scorza1, Esper A. Cavalheiro1, Jaderson Costa da Costa2
The first formal description of sudden cardiac death 
(SCD) was made as early as 4th century BC by the father 
of medicine, Hippocrates of Kos, which stated in his aph-
orisms that those who are subject to frequent and se-
vere fainting attacks without obvious cause die sudden-
ly1,2. Presently, in most textbooks SCD is defined as an 
unexpected death occurring within one hour from onset 
of symptoms in an individual with stable clinical con-
ditions before the onset of the life-threatening arrhyth-
mic event3,4,5. The magnitude of the problem is reflect-
ed on the fact that more than 7 million lives per year 
are lost to SCD worldwide1. In Europe, approximately 
350,000 individuals die each year due to SCD with un-
successful out-of-hospital cardiopulmonary resuscita-
tion6,7. The incidence of SCD in the United States ranges 
between 180,000 and 450,000 cases annually, depend-
ing on the definition used4,5,8,9,10. In a more specific way, 
prospective studies using multiple sources developed in 
the United States, Netherlands, Ireland, and China have 
shown that SCD rates ranging from 50 to 100 per 100 000 
in the general population10,11,12,13,14,15,16. The global burden 
of SCD remains high despite the fact that several factors 
have already been described which increase the risk of 
SCD in the general population9,10. It should not be ignored 
that epilepsy and seizures can have a profound effect on 
cardiovascular function and in some cases may be fa-
tal17,18. A number of questions should be raise to elucidate 
clearly the exact relationship between SCD and epilepsy. 
WHERE? Epilepsy is one of the most common neu-
rological conditions affecting at least 65 million people 
worldwide19,20. Individuals of all ages can be affected by 
it. It is treatable but often requires lifelong medication 
and sometimes surgery to control seizures21,22. Despite 
this, seizures in up to 40% of people with epilepsy do not 
respond properly to antiepileptic drugs or other treat-
ments23. In these individuals with refractory epilepsy, 
high rates of premature death compared with the gen-
eral population have recorded24,25. Sudden unexpected 
death in epilepsy (SUDEP) is a major cause of death in 
those people26. WHAT? The lack of autopsy results and 
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AbStrACt
Sudden unexpected death in epilepsy (SUDEP) is the most common cause of death in people with intractable epilepsy. Probably, optimization 
of seizure control will prevent some of these deaths. Briefly, we integrated in this paper some data about the epidemiology, risk factors, 
etiology, and preventative measures in the management of SUDEP.
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reSumo
A morte súbita nas epilepsias (SUDEP) é a causa mais comum de morte em indivíduos com epilepsia refratária. Provavelmente, o controle das 
crises epilépticas irá evitar algumas dessas mortes. Resumidamente, nós descrevemos nesse artigo alguns dados sobre a epidemiologia, 
fatores de risco, etiologia e medidas preventivas na SUDEP.
Palavras-chave: epilepsia; morte súbita.
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the rarely witnessed or monitored cases of SUDEP pose 
difficulties with regard to its pathophysiology and def-
initions18,27,28,29,30. SUDEP is generally defined as sudden, 
unexpected, witnessed or unwitnessed, nontraumatic 
and nondrowning death in patients with epilepsy, with 
or without evidence of a seizure and excluding docu-
mented status epilepticus, in which postmortem exami-
nation does not reveal a toxicologic or anatomical cause 
of death31. WHEN? The incidence of SUDEP is largely un-
derestimated due to differences in patient populations, 
study design, incomplete level of documentation and 
the criteria for diagnosing SUDEP18,27,30,32. Over the years, 
further refinements to knowledge of SUDEP incidence 
have been made. Briefly, it has been reported that SUDEP 
is responsible for up to 17% of all deaths in epilepsy33 
with an incidence rate among adults between 1:500 and 
1:1,000 patient-years while in children SUDEP varies on 
average 2/10.000 patient-years33,34. WHY? Recent research 
suggests that multiple risk factors may contribute for 
SUDEP but the by far most important clinical risk factor 
is the presence and the number of seizures mainly gener-
alized tonic-clonic seizures (GTCS)35. Additionally, other 
potential risk factors for SUDEP that should not be dis-
regarded have also been identified, including young age 
at epilepsy onset, longer duration of epilepsy, nocturnal 
seizures, dementia, absence of cerebrovascular disease, 
asthma, male gender, symptomatic etiology of epilepsy, 
alcohol abuse, and winter temperatures35,36,37,38. HOW? 
The precise mechanisms of SUDEP remain unknown39. 
It is also paramount to understand the mechanisms un-
derlying SUDEP as it may lead to the identification of 
previously unrecognized risk factors more amenable to 
intervention and key to prevention30,33,40. Although the 
cause or causes of SUDEP are still unknown, human and 
experimental research suggest that the major domains 
have been attributed to autonomic system, i.e., respirato-
ry and/or cardiovascular abnormalities during and after 
seizures18,27,39,40,41,42,43. From what is known to date, differ-
ent causal pathophysiological events should be highlight-
ed such as acute cardiovascular changes during seizures 
(tachyarrhythmias, bradyarrhythmias and ictal asystole), 
neurogenic pulmonary edema and respiratory distur-
bances with central and obstructive apnea17,36,40,42,43,44. 
As described previously, cardiac abnormalities and au-
tonomic dysfunction seem to be at the “heart” of the prob-
lem in SUDEP45. To this effect, the best approach is that of 
prevention. It is clear that our understanding of the best 
way to prevent SUDEP is still incomplete. Although strict 
evidence for their effectiveness is still lacking, some inter-
esting strategies have been suggested which could be use-
ful in reducing the risk of SUDEP30,40. Thus, possible preven-
tive strategies such as good control of seizures, reduction of 
stress, participation in physical activity and sports, dietary 
management (e.g., omega-3 supplementation) and super-
vision at night are already well formed46. Besides these as-
pects, a close convergence between neurologists and other 
medical specialties, especially cardiologists, it must also be 
present in the context and constantly encouraged by ex-
perts in the SUDEP field41,47,48.
Considering the guidelines, we agree with suggestions 
that patients with epilepsy, especially those at highest risk 
of SUDEP, should follow the comprehensive cardiovascular 
screening protocols (ECG, Holter-monitoring, echocardiog-
raphy, genetic analysis, ergometric exercise test and myo-
cardial scintigraphy, and, if abnormalities were found, cor-
onary angiography)41,49,50. Despite this SUDEP mechanisms 
are still a mystery, and the recent discoveries of genes and 
molecular systems involved in epilepsy and cardiovascular 
system41 are a cause for optimism that this issue could be 
solved quicker than anticipated.
Knowledge makes us wiser. In this sense, clinical and ani-
mal research is critical to understand accurately the close as-
sociation between SUDEP and seizures, and obviously, this is 
the primary goal of decreasing epilepsy-related deaths which 
figure high each year in mortality statistics.
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